Bavaria S, Chana A, Nurani KM, Kimang’a J. Recurrent hypoglycemia in a young female with nesidioblastosis: A case report and review of literature. World J Diabetes 2026; 17(3): 116660 [DOI: 10.4239/wjd.v17.i3.116660]
Corresponding Author of This Article
Khulud Mahmood Nurani, School of Medicine, University of Nairobi, Mbagathi Road, Nairobi 30197-00100, Kenya. khuludnurani@gmail.com
Research Domain of This Article
Endocrinology & Metabolism
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Mar 15, 2026 (publication date) through Mar 15, 2026
Times Cited of This Article
Times Cited (0)
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Bavaria S, Chana A, Nurani KM, Kimang’a J. Recurrent hypoglycemia in a young female with nesidioblastosis: A case report and review of literature. World J Diabetes 2026; 17(3): 116660 [DOI: 10.4239/wjd.v17.i3.116660]
World J Diabetes. Mar 15, 2026; 17(3): 116660 Published online Mar 15, 2026. doi: 10.4239/wjd.v17.i3.116660
Recurrent hypoglycemia in a young female with nesidioblastosis: A case report and review of literature
Shyam Bavaria, Amarpreet Chana, Khulud Mahmood Nurani, Joshua Kimang’a
Shyam Bavaria, Amarpreet Chana, Khulud Mahmood Nurani, Joshua Kimang’a, School of Medicine, University of Nairobi, Nairobi 30197-00100, Kenya
Author contributions: Bavaria S identified the case; Bavaria S, Chana A, Nurani KM and Kimang’a J drafted the case report.
Informed consent statement: Written informed consent was sought from the patient in line with ethical standards at the hospital.
Conflict-of-interest statement: The authors declare no conflict of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Corresponding author: Khulud Mahmood Nurani, School of Medicine, University of Nairobi, Mbagathi Road, Nairobi 30197-00100, Kenya. khuludnurani@gmail.com
Received: November 17, 2025 Revised: January 10, 2026 Accepted: February 5, 2026 Published online: March 15, 2026 Processing time: 115 Days and 13.4 Hours
Abstract
BACKGROUND
Nesidioblastosis is a rare condition involving abnormal proliferation of pancreatic β-cell, leading to excessive insulin production and severe hypoglycemia. In contrast to insulinomas, which are the most frequent cause of endogenous hyperinsulinism, nesidioblastosis lacks a definable mass, leaving the pancreas grossly unremarkable and invisible to conventional imaging techniques.
CASE SUMMARY
A 23-year-old female presented with a protracted 13-year history of recurrent hypoglycemia refractory to medical management (dextrose and diazoxide). Laboratory evaluation showed biochemical evidence of endogenous hyperinsulinism. Non-localizing conventional imaging was followed by a 68Ga-DOTATOC positron emission tomography/computed tomography scan, which demonstrated diffuse somatostatin-receptor uptake in the distal pancreas. The definitive diagnosis of nesidioblastosis was confirmed by histopathology following partial pancreatectomy.
CONCLUSION
This case highlights the diagnostic challenge associated with nesidioblastosis especially in resource-limited settings to enable early intervention.
Core Tip: Adult-onset nesidioblastosis is an uncommon but important cause of endogenous hyperinsulinism that can mimic insulinoma and lead to years of misdiagnosis. This case illustrates how persistent hypoglycemia despite standard medical therapy should prompt consideration of rare etiologies and the use of advanced imaging, such as 68Ga-DOTATOC positron emission tomography/computed tomography, when conventional studies are non-localizing. Early recognition improves the likelihood of timely surgical management and prevents prolonged morbidity.